These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 32971553)
1. [Pharmacotherapy in HFrEF]. Güder G; Frantz S Dtsch Med Wochenschr; 2020 Sep; 145(19):1384-1390. PubMed ID: 32971553 [TBL] [Abstract][Full Text] [Related]
2. Medical therapy of heart failure with reduced ejection fraction: current evidence and new developments. Naegele M; Flammer AJ; Enseleit F; Ruschitzka F Swiss Med Wkly; 2016; 146():w14295. PubMed ID: 26968014 [TBL] [Abstract][Full Text] [Related]
3. What constitutes optimal neurohumoral antagonism in chronic heart failure? Tajik AA; Dickstein K Heart; 2016 Dec; 102(23):1922-1932. PubMed ID: 27742799 [No Abstract] [Full Text] [Related]
9. Crunch time for heart failure care in England and Wales. Lancet; 2010 Dec; 376(9758):2041. PubMed ID: 21168037 [No Abstract] [Full Text] [Related]
10. MY APPROACH to the patient with heart failure and improved ejection fraction Cohn JN Trends Cardiovasc Med; 2018 Feb; 28(2):153. PubMed ID: 29032935 [No Abstract] [Full Text] [Related]
11. Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction: The CHECK-HF Registry. Brunner-La Rocca HP; Linssen GC; Smeele FJ; van Drimmelen AA; Schaafsma HJ; Westendorp PH; Rademaker PC; van de Kamp HJ; Hoes AW; Brugts JJ; JACC Heart Fail; 2019 Jan; 7(1):13-21. PubMed ID: 30606482 [TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center. Bress AP; King JB; Brixner D; Kielhorn A; Patel HK; Maya J; Lee VC; Biskupiak J; Munger M Pharmacotherapy; 2016 Feb; 36(2):174-86. PubMed ID: 26841333 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of Pharmacologic and Cardiac Implantable Electronic Device Therapies in Patients With Heart Failure and Reduced Ejection Fraction: A Systematic Review and Network Meta-Analysis. Tseng AS; Kunze KL; Lee JZ; Amin M; Neville MR; Almader-Douglas D; Killu AM; Madhavan M; Cha YM; Asirvatham SJ; Friedman PA; Gersh BJ; Mulpuru SK Circ Arrhythm Electrophysiol; 2019 Jun; 12(6):e006951. PubMed ID: 31159582 [TBL] [Abstract][Full Text] [Related]
14. Medical therapy following hospitalization for heart failure with reduced ejection fraction and association with discharge to long-term care: a cross-sectional analysis of the REasons for Geographic And Racial Differences in Stroke (REGARDS) population. Levitan EB; Van Dyke MK; Chen L; Durant RW; Brown TM; Rhodes JD; Olubowale O; Adegbala OM; Kilgore ML; Blackburn J; Albright KC; Safford MM BMC Cardiovasc Disord; 2017 Sep; 17(1):249. PubMed ID: 28915854 [TBL] [Abstract][Full Text] [Related]
15. Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials. Vaduganathan M; Claggett BL; Jhund PS; Cunningham JW; Pedro Ferreira J; Zannad F; Packer M; Fonarow GC; McMurray JJV; Solomon SD Lancet; 2020 Jul; 396(10244):121-128. PubMed ID: 32446323 [TBL] [Abstract][Full Text] [Related]
16. Physicians' adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey. Komajda M; Anker SD; Cowie MR; Filippatos GS; Mengelle B; Ponikowski P; Tavazzi L; Eur J Heart Fail; 2016 May; 18(5):514-22. PubMed ID: 27095461 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological management of chronic heart failure: old drugs, new drugs and new indications. Lim WY; Woldman S Br J Hosp Med (Lond); 2013 Feb; 74(2):C18-22. PubMed ID: 23411909 [No Abstract] [Full Text] [Related]